As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherapies designed for broader patient access.

By Julie Steenhuysen CHICAGO, May 31 (Reuters) - Revolution Medicine's experimental pancreatic cancer pill doubled survival compared with chemotherapy and improved symptoms enough that some patients could resume activities they had previously abandoned,

"One of the most amazing things I’ve ever seen," clinician-scientist Samuel Hume wrote alongside a video clip posted on X.

A targeted antibody‑drug conjugate shrinks tumors and slows progression in recurrent uterine cancer by ferrying potent chemotherapy directly into cancer cells.

New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.

Shares of Legend Biotech rose more than 40% Tuesday—on pace for the stock's biggest percentage increase on record—after the company said its experimental cancer treatment shrank tumors in all six patients who received the highest dose tested,

By Christy Santhosh June 2 (Reuters) - Celcuity shares slumped 25%, set for their biggest one-day decline, on Tuesday after its experimental breast cancer treatment extended the period of time a patient lives without the disease worsening but underperformed a previous trial.